Article
Current Treatment Methods in Pancreatic Cancer and the Need for Improvement
2024-10-21
Abstract excerpt
Pancreatic cancer, one of the deadliest cancers worldwide, necessitates improved therapeutics due to its low survival rate (12% in 5 years) and typically late-stage diagnosis [1]. This malignancy tends to present asymptomatically until advanced stages, leading to high rates of metastasis and limiting surgical options [2]. Genetic mutations in key genes like KRAS, CDKN2A, TP53, and SMAD4 are central to pancreatic c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a051296c-54f9-59d5-9eeb-f11c33411371
- DOI
- 10.20944/preprints202410.1569.v1